Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
139 studies found for:    Open Studies | "Fatty Acids, Omega-3"
Show Display Options
Rank Status Study
21 Recruiting Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer
Conditions: Arthralgia;   Breast Neoplasms
Interventions: Dietary Supplement: Omega-3 Fatty Acid;   Other: Placebo
22 Recruiting Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD
Condition: Children With ADHD Symptoms >90th Percentile (FBB-ADHS-V); no Beginning or Completion of Psychotherapeutically or Psychopharmalogical Treatment During the Study
Intervention: Dietary Supplement: omega-3/omega-6 fatty acids (PUFAs)
23 Not yet recruiting Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?
Condition: Major Depressive Disorder
Intervention: Dietary Supplement: Eicosapentaenoic acid enriched omega-3 fatty acids, 2 g/day
24 Recruiting Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention
Condition: Breast Cancer
Intervention: Dietary Supplement: omega 3 fatty acids
25 Not yet recruiting Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements
Condition: Sickle Cell Disease
Interventions: Dietary Supplement: Omega-3 capsules;   Dietary Supplement: Placebo
26 Recruiting High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
Conditions: ASA Triad;   Asthma, Nasal Polyps, And Aspirin Intolerance
Intervention: Behavioral: Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
27 Recruiting The Omega-3 Fatty Acid Paediatric Depression Trial
Condition: Depression
Interventions: Drug: Omega 3 fatty acid;   Drug: Placebo oil
28 Recruiting Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
Condition: Ultra High Risk for Psychosis
Interventions: Drug: Omega-3 fatty acids;   Other: Placebo
29 Recruiting Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Omegaven
30 Recruiting Effects of Omega-3 Fatty Acids in Ambient Air Pollution Exposure in Healthy Adults
Condition: Health Effects of Ambient Air Pollution
Intervention: Dietary Supplement: omega-3 fatty acids
31 Recruiting Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
Conditions: Attention Deficit Disorder With Hyperactivity;   ADHD Inattention or Mixed Type;   Epilepsy;   Child
Interventions: Drug: Vayarin®, supplementation of n-3 PUFA;   Drug: PLACEBO
32 Not yet recruiting Omega-3 vs Very Low Calorie Diet for Liver Size Reduction
Conditions: Obesity, Morbid;   Obesity;   NAFLD;   NASH - Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Very Low Calorie Diet
33 Recruiting The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)
Conditions: Pregnancy;   Depression
Interventions: Dietary Supplement: Omega-3 polyunsaturated fatty acids;   Dietary Supplement: Olive oil
34 Recruiting The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)
Conditions: Type 2 Diabetes Mellitus;   Hypertriglyceridemia
Interventions: Drug: Omega-3 fatty acid;   Drug: Placebos
35 Not yet recruiting Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides
Condition: Hypertriglyceridemia
Interventions: Drug: Omega-3-Acid Ethyl Esters 90 Soft Capsules;   Drug: Corn Oil
36 Recruiting Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy
Condition: Sarcopenia
Interventions: Dietary Supplement: Omega-3;   Dietary Supplement: Olive oil
37 Recruiting Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
Condition: Hyperlipidemia
Interventions: Drug: TAK-085;   Other: Not treated with omega-3-acid ethyl esters
38 Recruiting Polyunsaturated Fatty Acids in Patients With NAFLD.
Condition: NAFLD
Interventions: Dietary Supplement: Maxicor;   Other: Placebo
39 Recruiting High Dose Omega-3 Fatty Acids in the Treatment of Sport Related Concussions
Conditions: Mild Concussion;   Brain Concussion;   Cerebral Concussion
Interventions: Dietary Supplement: Docosahexaenoic acid;   Drug: Placebo
40 Recruiting Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States
Conditions: At Risk Mental State (ARMS);   Psychosis
Interventions: Drug: Minocycline;   Drug: Omega-3 fatty acids;   Drug: Placebo;   Drug: Minocycline Plus Omega-3 fatty acids

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.